Sponsor or institution
Clinical trials and research at Hummingbird Bioscience
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Hummingbird Bioscience that are recruiting, at sites in 6 countries (most in Australia (2), United States (1), Moldova (1)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 6Countries
All recruiting trials (2)
-
Assessing the safety and effectiveness of ENV-501 in patients with HER3-expressing solid tumors
This study is testing a new treatment called ENV-501 to see if it is safe and effective for people with advanced solid tumors that express HER3, like melanoma, lung cancer, and breast cancer.
-
Testing a new antibody treatment for advanced squamous cell cancers
This study is testing a new antibody treatment combined with chemotherapy for people with advanced squamous cell cancers that haven't responded to standard therapies.
Quick answers
How many clinical trials run by Hummingbird Bioscience are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Australia (2 trials), United States (1 trial), Moldova (1 trial), Singapore (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.